FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

MONDAY, May 21, 2018 -- Doptelet (avatrombopag) has been approved by the U.S. Food and Drug Administration to treat adults with chronic liver disease who are slated to have a medical or dental procedure. Doptelet was evaluated in a pair of clinical...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news